Peanut
- Generic Name
- Peanut
- Brand Names
- Palforzia 12 Mg (level 3), Palforzia 120 Mg (level 7), Palforzia 160 Mg (level 8), Palforzia 20 Mg (level 4), Palforzia 200 Mg (level 9), Palforzia 240 Mg (level 10), Palforzia 3 Mg (level 1), Palforzia 300 Mg (level 11), Palforzia 40 Mg (level 5), Palforzia 6 Mg (level 2), Palforzia 80 Mg (level 6), Palforzia Initial Dose Escalation
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- QE1QX6B99R
- Background
Peanut allergenic extract is used in allergenic testing.
- Associated Conditions
- -
- Associated Therapies
- -
Salvage Peanut Oral Immunotherapy Study
- First Posted Date
- 2017-08-16
- Last Posted Date
- 2023-01-30
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 15
- Registration Number
- NCT03251508
- Locations
- ๐บ๐ธ
University of North Carolina, Chapel Hill, North Carolina, United States
FARE Peanut SLIT and Early Tolerance Induction
- Conditions
- Food HypersensitivityPeanut AllergyPeanut HypersensitivityFood Allergy
- Interventions
- First Posted Date
- 2014-12-02
- Last Posted Date
- 2022-01-10
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 50
- Registration Number
- NCT02304991
- Locations
- ๐บ๐ธ
University of Texas Southwestern Medical Center, Dallas, Texas, United States
๐บ๐ธUniversity of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
Oral Peanut Immunotherapy for Peanut Allergic Patients
- First Posted Date
- 2013-07-02
- Last Posted Date
- 2015-06-25
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 36
- Registration Number
- NCT01891136
- Locations
- ๐บ๐ธ
UNC Chapel Hill, Chapel Hill, North Carolina, United States
Peanut Oral Immunotherapy (OIT) - Initial Pilot Study in Adults
- First Posted Date
- 2011-01-11
- Last Posted Date
- 2018-03-27
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 5
- Registration Number
- NCT01274429
- Locations
- ๐บ๐ธ
University of North Carolina, Chapel Hill, North Carolina, United States
Peanut Oral Immunotherapy and Anti-Immunoglobulin E (IgE) for Peanut Allergy
- Conditions
- Peanut Hypersensitivity
- Interventions
- First Posted Date
- 2009-07-03
- Last Posted Date
- 2018-03-01
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 13
- Registration Number
- NCT00932282
- Locations
- ๐บ๐ธ
University of North Carolina, Chapel Hill, North Carolina, United States
Determining the Efficacy and Value of Immunotherapy on the Likelihood of Peanut Tolerance: The DEVIL Study
- First Posted Date
- 2009-07-03
- Last Posted Date
- 2018-05-24
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 37
- Registration Number
- NCT00932828
- Locations
- ๐บ๐ธ
University of North Carolina, Chapel Hill, North Carolina, United States
Oral Immunotherapy (OIT) for Peanut Allergy
- First Posted Date
- 2008-12-29
- Last Posted Date
- 2018-03-01
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 16
- Registration Number
- NCT00815035
- Locations
- ๐บ๐ธ
University of North Carolina, Chapel Hill, North Carolina, United States
A Study of Sublingual Immunotherapy in Peanut-allergic Children
- First Posted Date
- 2008-01-18
- Last Posted Date
- 2018-03-27
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 60
- Registration Number
- NCT00597727
- Locations
- ๐บ๐ธ
University of North Carolina, Chapel Hill, North Carolina, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.